Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 13

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 13
---
refers to Keystone. “ Series A Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series A Preferred Stock, as amended from time to time. “ Series A Preferred Stock” refers to the Series A convertible preferred stock, $0.0001 par value per share, of CERo. “ Series A Warrants” refers to warrants to purchase Common Stock, at a current exercise price of $2,780.00 per share, sold to certain PIPE Investors pursuant to the First Securities Purchase Agreement. “ Series B Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series B Preferred Stock, as amended from time to time. “ Series B Preferred Stock” refers to the Series B convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series C Preferred Stock, as amended from time to time. “ Series C Preferred Stock” refers to the Series C convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Warrants” refers to warrants to purchase shares of Common Stock, at a current exercise price of $0.80 per share, sold to certain PIPE Investors pursuant to the Third Securities Purchase Agreement. “ Series D Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series D Preferred Stock, as amended from time to time. ix “ Series D Preferred Stock” refers to the Series D convertible preferred stock, $0.0001 par value per share, of CERo. “ Series E Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series E Preferred Stock, as amended from time to time. “ Series E Preferred Stock” refers to the Series E convertible preferred stock, $0.0001 par value per share, of CERo. “ Sponsor” refers to Phoenix Biotech Sponsor, LLC, a Delaware limited liability company. “ Tertiary Earnout Shares” refer to the 500 shares of Common Stock issued to the holders of Legacy CERo common stock and Legacy CERo preferred stock in connection with the Business Combination, which became fully vested upon the achievement of certain regulatory milestone-based earnout targets. “ Third PIPE Financing” refers to the private placement pursuant to which we issued and sold, and the PIPE Investors purchased, shares of Series C Preferred Stock, on